|
US7057017B2
(en)
|
1997-04-16 |
2006-06-06 |
Millennium Pharmaceuticals, Inc. |
Human dickkopf-related protein and nucleic acid molecules and uses therefor
|
|
JP2001514885A
(ja)
|
1997-08-19 |
2001-09-18 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
７０個のヒト分泌タンパク質
|
|
ES2286856T3
(es)
|
1997-09-12 |
2007-12-01 |
Biogen Idec Ma Inc. |
Receptores train ricos en cisteina.
|
|
US6849719B2
(en)
|
1997-09-17 |
2005-02-01 |
Human Genome Sciences, Inc. |
Antibody to an IL-17 receptor like protein
|
|
AU9482498A
(en)
*
|
1997-09-17 |
1999-04-05 |
Human Genome Sciences, Inc. |
Interleukin-17 receptor-like protein
|
|
US20030039648A1
(en)
|
1998-09-16 |
2003-02-27 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
US20030130182A1
(en)
*
|
1997-11-05 |
2003-07-10 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7446181B2
(en)
|
1998-01-15 |
2008-11-04 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind human Dickkopf-1 proteins
|
|
JP3577586B2
(ja)
|
1998-05-15 |
2004-10-13 |
ジェネンテック・インコーポレーテッド |
Ｉｌ−１７相同的ポリペプチドとその治療用途
|
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
|
US6344541B1
(en)
|
1998-09-25 |
2002-02-05 |
Amgen Inc. |
DKR polypeptides
|
|
US20030009013A1
(en)
|
1998-12-30 |
2003-01-09 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6291663B1
(en)
*
|
1999-03-03 |
2001-09-18 |
Board Of Trustees Of The University Of Arkansas |
TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma
|
|
US8133734B2
(en)
|
1999-03-16 |
2012-03-13 |
Human Genome Sciences, Inc. |
Kit comprising an antibody to interleukin 17 receptor-like protein
|
|
KR20100123890A
(ko)
*
|
1999-05-13 |
2010-11-25 |
메디칼 리서취 카운실 |
Ｏｘ2 수용체 동족체
|
|
US7034132B2
(en)
|
2001-06-04 |
2006-04-25 |
Anderson David W |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
EP1892249A1
(en)
*
|
1999-09-01 |
2008-02-27 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
ATE364689T1
(de)
|
1999-11-18 |
2007-07-15 |
Dendreon Corp |
Nukleinsäuren, welche für endotheliasen kodieren, endotheliasen, sowie deren verwendung
|
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
|
EP1897943B1
(en)
*
|
1999-12-23 |
2011-12-14 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
|
US20020155499A1
(en)
*
|
2000-09-25 |
2002-10-24 |
Leiby Kevin R. |
32624, a novel human UDP-glucuronosyl and glycosyl transferase family member and uses thereof
|
|
WO2002000857A2
(en)
*
|
2000-06-15 |
2002-01-03 |
Millennium Pharmaceuticals, Inc. |
53320, a human acyltransferase and uses therefor
|
|
US7094566B2
(en)
|
2000-03-16 |
2006-08-22 |
Amgen Inc., |
IL-17 receptor like molecules and uses thereof
|
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
|
WO2001083781A2
(en)
*
|
2000-04-28 |
2001-11-08 |
Millennium Pharmaceuticals, Inc. |
14094, a novel human trypsin family member and uses thereof
|
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030031675A1
(en)
|
2000-06-06 |
2003-02-13 |
Mikesell Glen E. |
B7-related nucleic acids and polypeptides useful for immunomodulation
|
|
CA2412377A1
(en)
|
2000-06-06 |
2001-12-13 |
Bristol-Myers Squibb Company |
B7-related nucleic acids and polypeptides and their uses for immunomodulation
|
|
EP1297133A2
(en)
*
|
2000-06-22 |
2003-04-02 |
Biogen, Inc. |
Gp354 nucleic acids and polypeptides
|
|
CA2413262A1
(en)
*
|
2000-06-30 |
2002-01-10 |
Amgen, Inc. |
B7-like molecules and uses thereof
|
|
US7402660B2
(en)
|
2000-08-02 |
2008-07-22 |
The Johns Hopkins University |
Endothelial cell expression patterns
|
|
CA2420392A1
(en)
*
|
2000-08-28 |
2002-03-07 |
Human Genome Sciences, Inc. |
17 human secreted proteins
|
|
AU2001283133A1
(en)
*
|
2000-09-01 |
2002-03-22 |
|
16658, 14223, and 16002, novel human kinases and uses therefor
|
|
WO2002040654A2
(en)
|
2000-11-14 |
2002-05-23 |
Bristol-Myers Squibb Company |
A human serpin secreted from lymphoid cells lsi-01
|
|
DE10106835A1
(de)
*
|
2001-02-14 |
2002-09-05 |
Basf Lynx Bioscience Ag |
Signaltransduktionsproteine 15B3, 15B3-1 und 15B3-2 und zugrundeliegende DNA-Sequenzen
|
|
WO2002064769A1
(en)
*
|
2001-02-15 |
2002-08-22 |
Shionogi & Co., Ltd. |
Novel disease marker
|
|
EP1873245A1
(en)
*
|
2001-02-28 |
2008-01-02 |
Genentech, Inc. |
Interleukin-8 homologous polypeptides and therapeutic uses thereof
|
|
EP1409655A4
(en)
*
|
2001-03-12 |
2005-04-06 |
Incyte Genomics Inc |
SUPERFAMILY PROTEINS OF IMMUNOGLOBULINS
|
|
AU2002305052A1
(en)
|
2001-03-13 |
2002-09-24 |
Corvas International, Inc. |
Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
|
|
US7172892B2
(en)
|
2001-03-22 |
2007-02-06 |
Dendreon Corporation |
Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon
|
|
EP1379637A4
(en)
|
2001-03-27 |
2005-04-06 |
Dendreon Corp |
TRANSMEMBRANE SERINE PROTEASE 9 CODING NUCLEIC ACID MOLECULES, THE POLYPEPTIDE CODED, AND METHODS FORMING THEREOF
|
|
US7033790B2
(en)
|
2001-04-03 |
2006-04-25 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
|
EP2280030A3
(en)
|
2001-04-10 |
2011-06-15 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
US7049096B2
(en)
|
2001-04-11 |
2006-05-23 |
Bristol-Meyers Squibb Company |
Polynucleotides encoding a novel human G-protein coupled receptor splice variant HGPRBMY29sv1
|
|
US7112430B2
(en)
|
2001-05-14 |
2006-09-26 |
Dendreon Corporation |
Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
|
|
WO2002101075A2
(en)
|
2001-06-13 |
2002-12-19 |
Millennium Pharmaceuticals, Inc. |
Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
|
|
CA2459985A1
(en)
*
|
2001-06-22 |
2003-01-03 |
Biogen, Inc. |
Pancam nucleic acids and polypeptides
|
|
WO2003004530A1
(en)
*
|
2001-07-06 |
2003-01-16 |
Bayer Aktiengesellschaft |
Regulation of human somatostatin receptor-like protein
|
|
JP2005502332A
(ja)
*
|
2001-07-26 |
2005-01-27 |
ジェンセット ソシエテ アノニム |
Ｇｍｇ−２ポリヌクレオチド及びポリペプチド並びにそれらの使用
|
|
JP4702819B2
(ja)
*
|
2001-08-01 |
2011-06-15 |
生化学工業株式会社 |
コンドロイチン合成酵素
|
|
WO2003018805A1
(fr)
*
|
2001-08-23 |
2003-03-06 |
Japan Science And Technology Agency |
Regulateurs de la proliferation de cellules souches hematopoietiques et polynucleotides codant ces regulateurs
|
|
WO2003099318A2
(en)
|
2002-05-29 |
2003-12-04 |
DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung |
Pancreas-specific proteins
|
|
EP2143438B1
(en)
|
2001-09-18 |
2011-07-13 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumors
|
|
AU2002333862A1
(en)
*
|
2001-09-20 |
2003-04-01 |
Bayer Aktiengesellschaft |
Regulation of human prolyl 4-hydroxylase alpha subunit precursor
|
|
WO2003088898A2
(en)
*
|
2002-04-17 |
2003-10-30 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
CA2466138A1
(en)
*
|
2001-11-02 |
2003-05-15 |
Shen Wu Wang |
B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
|
|
AU2002359815A1
(en)
|
2001-12-19 |
2003-07-09 |
Immunex Corporation |
C-type lectin polypeptide, polynucleotide and methods of making and use thereof
|
|
DE10211088A1
(de)
*
|
2002-03-13 |
2003-09-25 |
Ugur Sahin |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
EP1514926A4
(en)
*
|
2002-05-31 |
2006-01-11 |
Hidetoshi Inoko |
SLURP-2 GENE ASSOCIATED WITH INFLAMMATORY SKIN DISEASE AND USE THEREOF
|
|
WO2003102193A1
(fr)
*
|
2002-05-31 |
2003-12-11 |
Seikagaku Corporation |
Chondroitine synthetase et acide nucleique codant pour cette enzyme
|
|
EP2305710A3
(en)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
|
DE10242016A1
(de)
*
|
2002-09-11 |
2004-03-25 |
Esplora GmbH c/o TU Darmstadt Institut für Biochemie |
Verfahren zur Identifizierung BHS-spezifischer Proteine und Fragmente davon
|
|
CA2497337A1
(en)
*
|
2002-09-11 |
2004-03-25 |
Genentech, Inc. |
Novel composition and methods for the treatment of psoriasis
|
|
DE10254601A1
(de)
*
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
WO2004058817A1
(ja)
*
|
2002-12-26 |
2004-07-15 |
Takeda Pharmaceutical Company Limited |
新規タンパク質およびその用途
|
|
JP2007525142A
(ja)
*
|
2002-12-27 |
2007-09-06 |
アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ |
新規フィブリリン−様ポリペプチド
|
|
WO2004064740A2
(en)
*
|
2003-01-16 |
2004-08-05 |
University Of Virginia Patent Foundation |
Sperm specific lysozyme-like proteins
|
|
US7312197B2
(en)
|
2003-02-24 |
2007-12-25 |
University Of Maryland, Baltimore |
Method of modifying glucose activity using polypeptides selectively expressed in fat tissue
|
|
US20040185559A1
(en)
|
2003-03-21 |
2004-09-23 |
Isis Pharmaceuticals Inc. |
Modulation of diacylglycerol acyltransferase 1 expression
|
|
US7709610B2
(en)
|
2003-05-08 |
2010-05-04 |
Facet Biotech Corporation |
Therapeutic use of anti-CS1 antibodies
|
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
|
ES2424353T3
(es)
|
2003-07-08 |
2013-10-01 |
Genentech, Inc. |
Polipéptidos heterólogos IL-17 A/F y usos terapéuticos de los mismos
|
|
JP2007528721A
(ja)
|
2003-08-14 |
2007-10-18 |
ダイアックス コーポレイション |
エンドセリアーゼ−２リガンド
|
|
US7825235B2
(en)
|
2003-08-18 |
2010-11-02 |
Isis Pharmaceuticals, Inc. |
Modulation of diacylglycerol acyltransferase 2 expression
|
|
EP1712619A4
(en)
*
|
2003-12-24 |
2008-01-02 |
Takeda Pharmaceutical |
MEANS FOR PREVENTING / CUREING CANCER
|
|
DE102004024617A1
(de)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
CN101010342A
(zh)
|
2004-07-02 |
2007-08-01 |
健泰科生物技术公司 |
用于治疗非何杰金淋巴瘤的组合物和方法
|
|
EP1789070B1
(en)
|
2004-08-03 |
2012-10-24 |
Biogen Idec MA Inc. |
Taj in neuronal function
|
|
MX2007001221A
(es)
|
2004-08-04 |
2007-03-23 |
Amgen Inc |
Anticuerpos para proteina dickkopf-1 (dkk-1).
|
|
US7544659B2
(en)
|
2004-08-13 |
2009-06-09 |
Genentech, Inc. |
Promotion of axonal regeneration
|
|
JP2008532516A
(ja)
*
|
2005-03-11 |
2008-08-21 |
ジェネンテック・インコーポレーテッド |
遺伝子破壊、組成物、およびそれに関連する方法
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
NZ568015A
(en)
|
2005-12-08 |
2012-03-30 |
Medarex Inc |
Human monoclonal antibodies to O8E
|
|
WO2007107774A2
(en)
*
|
2006-03-22 |
2007-09-27 |
Cartela R & D Ab |
Integrin alpha-10 subunit as therapeutic target and diagnostic/prognostic marker for cancer
|
|
JP2009536022A
(ja)
*
|
2006-04-19 |
2009-10-08 |
ジェネンテック・インコーポレーテッド |
新規の遺伝子破壊、それに関連する組成物および方法
|
|
US8003620B2
(en)
|
2006-08-04 |
2011-08-23 |
Isis Pharmaceuticals, Inc. |
Compositions and their uses directed to diacylglycerol acyltransferase 1
|
|
DK2069793T3
(en)
|
2006-08-29 |
2017-04-24 |
Oxford Biotherapeutics Ltd |
IDENTIFICATION OF PROTEIN IN CONNECTION WITH HEPATOCELLULAR CARCINOMA, GLIOBLASTOMA AND LUNG CANCER
|
|
US8058014B2
(en)
|
2006-09-29 |
2011-11-15 |
University Of Maryland, Baltimore |
Method of diagnosing or predicting disease states in a subject using omentin 1 and omentin 2
|
|
KR20150002874A
(ko)
|
2008-05-05 |
2015-01-07 |
노비뮨 에스 에이 |
항-ｉｌ-１７ａ／ｉｌ-１７ｆ 교차-반응성 항체 및 그의 사용 방법
|
|
CN102112147B
(zh)
*
|
2008-06-02 |
2014-05-21 |
达纳-法伯癌症研究所股份有限公司 |
Xbp1、cd138、和cs1肽
|
|
ME02842B
(me)
|
2009-03-05 |
2018-01-20 |
Squibb & Sons Llc |
Potpuno ljudska antitijela specifična za cadm1
|
|
US8137671B2
(en)
|
2009-05-05 |
2012-03-20 |
Genentech, Inc. |
Anti-IL-17F antibodies
|
|
WO2013167153A1
(en)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Antibodies useful in cancer diagnosis
|
|
WO2013174404A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
AU2013337247B2
(en)
|
2012-11-05 |
2018-08-09 |
Dana-Farber Cancer Institute, Inc. |
XBP1, CD138, and CS1 peptides, pharmaceutical compositions that include the peptides, and methods of using such peptides and compositions
|
|
NZ746691A
(en)
|
2012-11-13 |
2020-08-28 |
Astellas Pharma Inc |
Agents for treatment of claudin expressing cancer diseases
|
|
WO2014127785A1
(en)
|
2013-02-20 |
2014-08-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
WO2014146672A1
(en)
|
2013-03-18 |
2014-09-25 |
Ganymed Pharmaceuticals Ag |
Therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
MY192997A
(en)
|
2015-07-10 |
2022-09-20 |
Ionis Pharmaceuticals Inc |
Modulators of diacyglycerol acyltransferase 2 (dgat2)
|